# Triumph Financial, Inc.: financial statements, quarterly

TFIN · NYSE · CIK 1539638 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tfin.md) · [Financials](/companies/tfin/financials.md) · [Filings](/companies/tfin/filings.md) · [Insiders](/companies/tfin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tfin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [16.8 d](/filings/0001628280-24-004458.md) | [15.9](/filings/0001628280-24-016581.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.1 d](/filings/0001539638-26-000007.md) | [0.6](/filings/0001628280-25-017991.md) | [0.8](/filings/0001628280-25-035066.md) | [0.9](/filings/0001539638-25-000020.md) | [2.0 d](/filings/0001539638-26-000007.md) | [0.1](/filings/0001539638-26-000016.md) | [3.5](/filings/0001539638-26-000029.md) | [(0.4)](/filings/0001539638-26-000037.md) | [4.5 d](/filings/0001539638-26-000007.md) | [1.8](/filings/0001539638-26-000016.md) | [4.5](/filings/0001539638-26-000029.md) | [5.1](/filings/0001539638-26-000037.md) |
| Net income | $m | [9.6 d](/filings/0001539638-26-000007.md) | [4.2](/filings/0001539638-25-000020.md) | [2.7](/filings/0001539638-25-000020.md) | [5.3](/filings/0001539638-25-000020.md) | [3.8 d](/filings/0001539638-26-000007.md) | [0.0](/filings/0001539638-26-000037.md) | [4.4](/filings/0001539638-26-000037.md) | [1.7](/filings/0001539638-26-000037.md) | [19.2 d](/filings/0001539638-26-000007.md) | [6.4](/filings/0001539638-26-000037.md) | [11.4](/filings/0001539638-26-000037.md) | [13.4](/filings/0001539638-26-000037.md) |
| Diluted EPS | $ per share | not reported | [0.14](/filings/0001628280-25-017991.md) | [0.08](/filings/0001628280-25-035066.md) | [0.19](/filings/0001539638-25-000020.md) | not reported | [(0.03)](/filings/0001539638-26-000016.md) | [0.15](/filings/0001539638-26-000029.md) | [0.04](/filings/0001539638-26-000037.md) | not reported | [0.23](/filings/0001539638-26-000016.md) | [0.44](/filings/0001539638-26-000029.md) | [0.52](/filings/0001539638-26-000037.md) |
| Basic EPS | $ per share | not reported | [0.14](/filings/0001628280-25-017991.md) | [0.08](/filings/0001628280-25-035066.md) | [0.19](/filings/0001539638-25-000020.md) | not reported | [(0.03)](/filings/0001539638-26-000016.md) | [0.15](/filings/0001539638-26-000029.md) | [0.04](/filings/0001539638-26-000037.md) | not reported | [0.23](/filings/0001539638-26-000016.md) | [0.44](/filings/0001539638-26-000029.md) | [0.53](/filings/0001539638-26-000037.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [287](/filings/0001628280-25-004879.md) | [417](/filings/0001628280-24-016581.md) | [501](/filings/0001628280-24-032079.md) | [489](/filings/0001628280-24-042923.md) | [330](/filings/0001539638-26-000007.md) | [503](/filings/0001628280-25-017991.md) | [282](/filings/0001628280-25-035066.md) | [147](/filings/0001539638-25-000020.md) | [248](/filings/0001539638-26-000037.md) | [582](/filings/0001539638-26-000016.md) | [897](/filings/0001539638-26-000029.md) | [1,033](/filings/0001539638-26-000037.md) |
| Total assets | $m | [5,347](/filings/0001628280-25-004879.md) | [5,575](/filings/0001628280-24-016581.md) | [5,783](/filings/0001628280-24-032079.md) | [5,866](/filings/0001628280-24-042923.md) | [5,949](/filings/0001539638-26-000007.md) | [6,268](/filings/0001628280-25-017991.md) | [6,495](/filings/0001628280-25-035066.md) | [6,357](/filings/0001539638-25-000020.md) | [6,381](/filings/0001539638-26-000037.md) | [6,877](/filings/0001539638-26-000016.md) | [7,404](/filings/0001539638-26-000029.md) | [7,680](/filings/0001539638-26-000037.md) |
| Total liabilities | $m | [4,483](/filings/0001628280-25-004879.md) | [4,703](/filings/0001628280-24-016581.md) | [4,909](/filings/0001628280-24-032079.md) | [4,980](/filings/0001628280-24-042923.md) | [5,058](/filings/0001539638-26-000007.md) | [5,374](/filings/0001628280-25-017991.md) | [5,582](/filings/0001628280-25-035066.md) | [5,438](/filings/0001539638-25-000020.md) | [5,439](/filings/0001539638-26-000037.md) | [5,926](/filings/0001539638-26-000016.md) | [6,440](/filings/0001539638-26-000029.md) | [6,702](/filings/0001539638-26-000037.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [864](/filings/0001539638-26-000007.md) | [872](/filings/0001539638-25-000020.md) | [874](/filings/0001539638-25-000020.md) | [886](/filings/0001539638-25-000020.md) | [891](/filings/0001539638-26-000037.md) | [894](/filings/0001539638-26-000037.md) | [912](/filings/0001539638-26-000037.md) | [919](/filings/0001539638-26-000037.md) | [942](/filings/0001539638-26-000037.md) | [951](/filings/0001539638-26-000037.md) | [963](/filings/0001539638-26-000037.md) | [979](/filings/0001539638-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [42.1 d](/filings/0001539638-26-000007.md) | [(10.7)](/filings/0001628280-25-017991.md) | [21.9 d](/filings/0001628280-25-035066.md) | [26.6 d](/filings/0001539638-25-000020.md) | [20.8 d](/filings/0001539638-26-000007.md) | [(3.6)](/filings/0001539638-26-000016.md) | [9.8 d](/filings/0001539638-26-000029.md) | [24.4 d](/filings/0001539638-26-000037.md) | [36.5 d](/filings/0001539638-26-000007.md) | [5.1](/filings/0001539638-26-000016.md) | [46.2 d](/filings/0001539638-26-000029.md) | [25.6 d](/filings/0001539638-26-000037.md) |
| Capital expenditure | $m | not reported | not reported | not reported | [0.8 d](/filings/0001539638-25-000020.md) | not reported | [4.2](/filings/0001539638-26-000016.md) | [3.0 d](/filings/0001539638-26-000029.md) | [2.0 d](/filings/0001539638-26-000037.md) | not reported | [1.7](/filings/0001539638-26-000016.md) | [3.5 d](/filings/0001539638-26-000029.md) | [4.3 d](/filings/0001539638-26-000037.md) |
| Dividends paid | $m | [0.8 d](/filings/0001539638-26-000007.md) | [0.8](/filings/0001628280-25-017991.md) | [0.8 d](/filings/0001628280-25-035066.md) | [0.8 d](/filings/0001539638-25-000020.md) | [0.8 d](/filings/0001539638-26-000007.md) | [0.8](/filings/0001539638-26-000016.md) | [0.8 d](/filings/0001539638-26-000029.md) | [0.8 d](/filings/0001539638-26-000037.md) | [0.8 d](/filings/0001539638-26-000007.md) | [0.8](/filings/0001539638-26-000016.md) | [0.8 d](/filings/0001539638-26-000029.md) | [0.8 d](/filings/0001539638-26-000037.md) |
| Share repurchases | $m | [0.0 d](/filings/0001539638-26-000007.md) | [0.1](/filings/0001628280-25-017991.md) | [3.2 d](/filings/0001628280-25-035066.md) | [0.0 d](/filings/0001539638-25-000020.md) | [(0.0) d](/filings/0001539638-26-000007.md) | [0.1](/filings/0001539638-26-000016.md) | [2.1 d](/filings/0001539638-26-000029.md) | [0.0 d](/filings/0001539638-26-000037.md) | [0.0 d](/filings/0001539638-26-000007.md) | [0.1](/filings/0001539638-26-000016.md) | [2.1 d](/filings/0001539638-26-000029.md) | [0.0 d](/filings/0001539638-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.8](/filings/0001628280-24-016581.md) | [23.5](/filings/0001628280-24-032079.md) | [23.5](/filings/0001628280-24-042923.md) | [23.7](/filings/0001628280-25-017991.md) | [23.7](/filings/0001628280-25-035066.md) | [23.7](/filings/0001539638-25-000020.md) | [23.4](/filings/0001539638-26-000016.md) | [23.8](/filings/0001539638-26-000029.md) | [23.9](/filings/0001539638-26-000037.md) | [24.0](/filings/0001539638-26-000016.md) | [24.1](/filings/0001539638-26-000029.md) | [24.1](/filings/0001539638-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,921,510 at 2026-10-19, from the cover of the [10-Q filed 2026-10-21](/filings/0001539638-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.